Key Takeaways:
The Supreme Court issued an extension on the pause on the mifepristone ban until Friday, April 20th.
The Supreme Court is currently still deliberating whether to allow a federal restriction on the abortion pill mifepristone.
Mifepristone is a critical medication used in the most common method of abortion in the United States.
Restrictions on mifepristone could harm millions of women who rely on it for reproductive healthcare.
WEDNESDAY, APRIL 19 - The Supreme Court is extending access to Mifepristone, a commonly used abortion pill, until at least Friday. The court is deciding whether to allow restrictions on the drug mifepristone to take effect.
Reproductive Autonomy At Stake
At issue is whether to enforce limits on mifepristone ordered by a lower court while a legal challenge to the medication's FDA approval continues.
With restrictions on this crucial drug at stake, we must stand firm and recognize the importance of mifepristone for millions of women in the United States.
Mifepristone, a critical component in medication abortions, has been empowering women's reproductive autonomy since its FDA approval in 2000. When combined with misoprostol, it offers a safe, reliable option for inducing abortions.
So far, more than 5 million women have utilized this life-changing medication, and yet, the Supreme Court is now deliberating on imposing restrictions.
Defend Women's Reproductive Healthcare
The Biden administration and Danco Laboratories, the manufacturer of the drug, are urging the Supreme Court to reject these unwarranted limitations.
They argue that restricting mifepristone would wreak havoc on the lives of women who rely on the drug and the providers who supply it. However, anti-abortion doctors and medical groups are pushing for restrictions on mifepristone.
It's essential to understand that medication abortions account for more than half of all abortions in the United States. As such, any restrictions on mifepristone would have dire consequences for women's reproductive healthcare.
We cannot afford to back down on this issue.
Fighting for What's Right
In this ongoing battle for reproductive rights and justice, we must remain vigilant and steadfast in our support for mifepristone accessibility and reproductive health, rights, and justice. By doing so, we're not only defending the autonomy of millions of women but also safeguarding a cornerstone of reproductive healthcare.
Let's come together, raise our voices, and ensure that mifepristone remains accessible for those who need it most.
